The Malaria Research Program is a collaborative group of researchers from several NIAID laboratories whose goal is to bring fresh, innovative, and interdisciplinary approaches to malaria research. The program also provides training opportunities for students and postdoctoral fellows who will be future leaders of malaria programs.
The mission of the DIR Malaria Research Program (MRP) is to seek fundamental knowledge about the interactions of malaria parasites with the human host and the mosquito vectors that transmit them and to apply this knowledge to prevent disease, enhance health, and improve the quality of life in malaria endemic areas.
This fundamental knowledge would be the basis to develop new malaria control strategies such as the following:
MRP DirectorDr. Carolina Barillas-MuryChief, Mosquito Immunity and Vector Competence Section, Laboratory of Malaria and Vector Research (LMVR)
MRP Executive CommitteeDr. Patrick DuffyChief, Laboratory of Malaria Immunology and Vaccinology (LMIV)
Dr. Susan PierceChief, Laboratory of Immunogenetics (LIG)
Dr. Thomas WellemsChief, Laboratory of Malaria and Vector Research
MRP investigators explore the biology of malaria from the perspective of the human host, the Plasmodium parasite, and the mosquito vector and the interactions among them.
Thomas WellemsMalaria Genetics Section
Sanjay DesaiApicomplexan Molecular Physiology Section
Louis MillerMalaria Cell Biology Section
Xinzhuan SuMalaria Functional Genomics Section
Patrick DuffyPathogenesis and Immunity Section
Michal FriedMolecular Pathogenesis and Biomarkers Section
Sue PierceLymphocyte Activation Section
Peter CromptonMalaria Infection Biology and Immunity Unit
Rick FairhurstMalaria Pathogenesis and Human Immunity Unit
Tian JinChemotaxis Signal Section
Eric LongMolecular and Cellular Immunology Section
Silvia BollandAutoimmunity and Functional Genomics Section
Carole LongMalaria Immunology Section
Carolina Barillas-MuryMosquito Immunity and Vector Competence Section
To meet the greatest challenges in malaria research, contemporary studies often rely on collaborative efforts between individual investigators with expertise in different areas. NIAID scientists who study malaria in three separate laboratories have come together to form the Malaria Research Program (MRP) and promote collaborative environments and facilitate next-level breakthroughs in malaria research. The goal of the MRP is to create, strengthen, and sustain interactions within MRP and with other NIH-based investigators who are using diverse yet complementary approaches to tackle the global malaria problem.
The MRP Collaborative Research Fellowship will be awarded annually to a limited number of top applicants who aspire to improve our understanding of the biology, host-pathogen interactions, and transmission of malaria parasites. MRP fellows are expected to play a central role in initiating and maintaining close, balanced, and productive collaborations between two laboratories in the MRP or between the MRP and another NIH-based research program. To help successful applicants gain the knowledge base and skills necessary to launch their own scientific careers, the MRP Collaborative Research Fellowship will provide them the opportunities to do the following:
NIAID has a decades-long history of making advances in malaria research, including seminal discoveries that significantly improved our understanding of malaria pathogenesis, immunity and vaccinology, human and vector resistance to parasite infection and disease, and parasite resistance to antimalarial drugs.
MRP investigators envision that a more collaborative approach to research will drive the future development of affordable, point-of-care diagnostics for malaria and drug-resistant parasite infections; highly effective drugs that target essential parasite functions and are less vulnerable to acquired drug-resistance mechanisms; vaccines and adjunctive therapies that reduce the morbidity, mortality, and transmission of malaria; and novel strategies that block parasite development in mosquito vectors.
Last Updated August 20, 2015